| Value | ₹1.35 Cr |
|---|
NSE filing, NSE: ADVENZYMES. Summary written from the filing by ALFA Finder's alert engine.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹259.75
- Market cap
- ₹2,909 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 17.5×Sector 46.1×
- Promoter holding
- 43.56%+0.32% QoQ
- FII holding
- 26.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 29,115 shares on October 27, 2026, worth about ₹0.75 Crore. Cumulative buyback stands at 22,91,868 shares under its open-market programme.
- Value
- ₹0.75 Cr
Advanced Enzyme Technologies Board Meeting Date
Advanced Enzyme Technologies will hold a board meeting on 31 October 2026 to approve Q2 and H1 FY27 unaudited results. The trading window stays closed until 2 November 2026.
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 58,326 equity shares at an average price of ₹263.3605 per share on October 22, 2026.
- Value
- ₹1.54 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies Ltd. received a request from Snehal Shamsunder Soni to reclassify their shareholding from the 'Promoter Group' to the 'Public' category.
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies reported the daily buyback of 55,794 shares from the open market at an average price of Rs. 267.5974 per share.
- Value
- ₹1.49 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.